TUESDAY, Oct. 6, 2020 (HealthDay News)
For some patients suffering from appendicitis, antibiotics may do the trick, a large U.S. trial suggests.
More than 70% of patients who received antibiotics avoided surgery for at least 90 days, according to the new report.
“When we compared the outcomes of people treated with antibiotics alone or surgery to remove the appendix, we found that people receiving either treatment felt well at 30 days,” said co-principal investigator Dr. David Talan. “In terms of overall health status, antibiotics were no worse than surgery and allowed most people to avoid an operation in the short term.”
Talan is a professor of emergency medicine and infectious diseases at the David Geffen School of Medicine at UCLA.
In the trial, more than 1,500 patients in 14 U.S. states randomly received antibiotics first or an appendectomy. The trial is the largest ever clinical randomized look at appendicitis treatment, the study authors said.
According to Bonnie Bizzell, chairwoman of the trial’s patient advisory board, “People treated with antibiotics more often returned to the emergency department, but missed less time from work and school. Information like this can be important for individuals as they consider the best treatment option for their unique circumstance.”
About three in 10 patients given antibiotics had surgery within 90 days, according to researcher Dr. David Flum, associate chairman of surgery at the University of Washington School of Medicine, in Seattle. “There were advantages and disadvantages to each treatment, and patients will value these differently based on their unique characteristics, concerns and perspectives.”
Initial treatment with antibiotics created a higher risk for patients with an appendicolith — a calcified deposit within the appendix that occurs in roughly one-quarter of patients. It is associated with more complications and a 40% chance of surgery within 90 days, the researchers said.
The findings were published online Oct. 5 in the New England Journal of Medicine.
— Steven Reinberg
Copyright © 2020 HealthDay. All rights reserved.
SOURCE: University of California, Los Angeles, news release, Oct. 5, 2020
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022